REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Acatavir Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Secondary Activities: Scientific Research and Development Services
Full name: Acatavir Sp. z o.o. Profile Updated: April 03, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Acatavir Sp. z o.o. is based in Poland. The head office is in Krakow. It operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. The company was established on November 30, 2020. During that time, Acatavir Sp. z o.o.’s total assets grew by 3.81%.

Headquarters
Ul. Profesora Michala Bobrzynskiego 14
Krakow; Malopolskie; Postal Code: 30-348

Contact Details: Purchase the Acatavir Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Acatavir Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Acatavir Sp. z o.o. report to view the information.
Incorporation Date:
November 30, 2020
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
10%
Purchase this report to view the information.
10%
Purchase this report to view the information.
10%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Acatavir Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating Profit/Loss (EBIT)
-954.12%▼
EBITDA
-954.12%▼
Net Profit/Loss for the Period
-677.79%▼
Total Assets
3.81%▲
Total Equity
66.65%▲
Return on Equity (ROE)
-4.67%▼
Debt/Equity
-0.13%▼
Quick Ratio
913.68%▲
Cash Ratio
7.74%▲

Similar companies

"Astrazeneca Pharma Poland" Sp. z o.o.
 
Instytut "Pomnik - Centrum Zdrowia Dziecka"
Instytut "Centrum Zdrowia Matki Polki"
 
Eviden Poland R&D Sp. z o.o.
Narodowy Instytut Kardiologii Stefana Kardynala Wyszynskiego - Panstwowy Instytut Badawczy
 
Instytut Hematologii I Transfuzjologii
"Green Park VI" Sp. z o.o.
 
Airror Sp. z o.o.
Car Technology Design Sp. z o.o.
 
Medinice B+R Sp. z o.o.
Medai Sp. z o.o.
 

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo